A recently discovered blood test could help physicians to find out much quicker the incidence of heart attacks in their patients. This type of analysis effectively showed experts which participants were not suffering a stroke after just one sample of their blood. It is a significant improvement in comparison to current tests that require a few hours and a series of blood exams.
The main objective would be to require a single drop of blood for most cardiac affection sufferers. Such innovative tests could help more than half of the patients with pain in their chest area to go through the emergency rooms quicker, thus saving save their time, and even life.
The new research is similar to previous ones, but it is a lot more sensitive to troponins, a type of protein that is released into the circulatory system when our heart is at risk. Typically, physicians run different troponin tests over the course of a day. If protein values are still within regular limits after this critical interval of time, cardiac arrest is unlikely to happen.
These results come after a pair of separate studies revealed in American medical journals. In the first one, for 4,500 people who arrived to ER in recent years with signs of a possible cardiac arrest, scientists used various high-sensitivity troponin tests.
They analyzed the information from those sufferers to find out which lowest value of troponin in the circulatory system would effectively show that a patient is not suffering a heart attack. Fortunately, 3,800 of those subjects did not suffer a sudden stroke and more than 60 percent of them had their troponin levels below 5 nanograms per liter (ng/L). Under this critical cutoff, the scientists concluded that is a over 99% probability that individuals are not at risk of having heart attacks within the next month.
Next, the doctors duplicated these results in another 1,000 patients with various heart problems. What this new research reveals is that sufferers who have less than 5 ng/L are not at immediate risk. These people may be allowed to go to their house or to be kept under surveillance by their physician.
The outcomes are fairly exciting and compelling. But, the study is a not an ideal solution and some individuals who are having strokes might be mislead by these quick conclusions. There is an opportunity to advance in this field, but it is incredibly hard to develop a system that could be efficient for all patients. Even if the analysis is precise, doctors have to perform it along with extra follow-up tests. Those with cardiac problems will also get assessments and electrocardiograms by physicians and nursing staff.
When it comes to cardiac sufferers, their doctor is still the most competent person who is able to evaluate negative analysis along with the rest of medical tools. Critics of the newly found method said that these tests were less efficient when they were performed within three hours after the symptoms appeared.
The scientists will keep assessing the flaws of the method in a real world environment. The test’s price is around $8 and the group of specialists is almost finishing a cost-benefit research. The reduced costs might prove to be an essential advantage in the large adoption of this method in many hospitals and clinics, not only in the United States, but all over the world.
Image source: Abcnews